Total Payments
$5,108
2024 Payments
$857.78
Companies
26
Transactions
246
Medicare Patients
830
Medicare Billing
$46,393
Payment Breakdown by Category
Food & Beverage$4,869 (95.3%)
Education$168.13 (3.3%)
Research$70.05 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,869 | 238 | 95.3% |
| Education | $168.13 | 7 | 3.3% |
| Unspecified | $70.05 | 1 | 1.4% |
Payments by Type
General
$5,038
245 transactions
Research
$70.05
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $781.81 | 46 | $0 (2024) |
| Merck Sharp & Dohme LLC | $457.15 | 31 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $436.34 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $424.56 | 21 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $423.63 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $417.17 | 15 | $0 (2024) |
| HeartFlow, Inc. | $252.38 | 3 | $0 (2022) |
| Amgen Inc. | $238.03 | 15 | $0 (2024) |
| PFIZER INC. | $232.73 | 12 | $0 (2024) |
| Abbott Laboratories | $194.30 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $857.78 | 41 | Novartis Pharmaceuticals Corporation ($203.21) |
| 2023 | $1,031 | 45 | Novartis Pharmaceuticals Corporation ($160.92) |
| 2022 | $1,650 | 70 | Novartis Pharmaceuticals Corporation ($261.44) |
| 2021 | $1,569 | 90 | AstraZeneca Pharmaceuticals LP ($277.41) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $105.77 | General |
| Category: Renal Denervation System | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $41.14 | General |
| Category: ANTIBIOTIC | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.01 | General |
| 06/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 05/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiology | ||||||
| 04/25/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: DIABETES | ||||||
| 04/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiology | ||||||
| 04/03/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.18 | General |
| 04/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.15 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PIV Patient Identification | ABIOMED | $70.05 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 449 | 472 | $77,620 | $29,334 |
| 2022 | 2 | 36 | 36 | $1,782 | $698.87 |
| 2021 | 4 | 79 | 79 | $11,267 | $2,492 |
| 2020 | 7 | 266 | 290 | $40,983 | $13,868 |
Total Patients
830
Total Services
877
Medicare Billing
$46,393
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 183 | $39,894 | $15,246 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 133 | $20,482 | $7,714 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 37 | $11,322 | $4,342 | 38.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 22 | $2,178 | $789.66 | 36.3% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 26 | 26 | $1,560 | $557.28 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 45 | 45 | $1,170 | $399.66 | 34.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 26 | 26 | $1,014 | $286.04 | 28.2% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2022 | 18 | 18 | $1,080 | $454.47 | 42.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 18 | 18 | $702.00 | $244.40 | 34.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 34 | $7,653 | $1,457 | 19.0% |
| 93017 | Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring | Office | 2021 | 16 | 16 | $960.00 | $433.44 | 45.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $2,030 | $364.73 | 18.0% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2021 | 16 | 16 | $624.00 | $236.48 | 37.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 118 | 134 | $25,326 | $8,560 | 33.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 54 | $6,912 | $2,405 | 34.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 15 | $3,825 | $1,207 | 31.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 18 | $2,304 | $881.55 | 38.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 40 | 41 | $1,230 | $386.21 | 31.4% |
| 93017 | Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring | Office | 2020 | 14 | 14 | $840.00 | $276.52 | 32.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2020 | 14 | 14 | $546.00 | $151.95 | 27.8% |
About Michael Clark, PA
Michael Clark, PA is a Physician Assistant healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326006834.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Clark, PA has received a total of $5,108 in payments from pharmaceutical and medical device companies, with $857.78 received in 2024. These payments were reported across 246 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,869).
As a Medicare-enrolled provider, Clark has provided services to 830 Medicare beneficiaries, totaling 877 services with total Medicare billing of $46,393. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Bedford, TX
- Active Since 05/03/2006
- Last Updated 03/15/2012
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1326006834
Products in Payments
- ENTRESTO (Drug) $477.54
- VERQUVO (Drug) $457.15
- Vascepa (Drug) $424.56
- JARDIANCE (Drug) $417.17
- LEQVIO (Drug) $304.27
- FFRct (Device) $252.38
- UPTRAVI (Drug) $246.63
- Repatha (Biological) $216.09
- ELIQUIS (Drug) $212.02
- FARXIGA (Drug) $200.81
- XARELTO (Drug) $194.26
- OPSUMIT (Drug) $189.71
- NEXLETOL (Drug) $185.45
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $171.19
- ONPATTRO (Drug) $128.40
- MULTAQ (Drug) $113.08
- SYMPLICITY G3 (Device) $105.77
- LifeVest (Device) $102.44
- Impella (Device) $70.05
- NUZYRA (Drug) $41.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Bedford
Jerry John
Physician Assistant — Payments: $5,297
Physician Assistant $5,297
Cory Logan, Pa-C, PA-C
Physician Assistant — Payments: $4,672
Physician Assistant $4,672
Amy De La Rosa, Pa-C, PA-C
Physician Assistant — Payments: $3,146
Physician Assistant $3,146
Lauren Hooper
Physician Assistant — Payments: $2,718
Physician Assistant $2,718
Lauren Edwards, Pa-C, PA-C
Physician Assistant — Payments: $2,340
Physician Assistant $2,340
Micala Abbiati, Pa-C, PA-C
Physician Assistant — Payments: $1,860
Physician Assistant $1,860